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 The known 
 The number of vulvoplasty procedures has been rising over the last decade 
The new 
 One in ten women with vulvoplasty also have had, or will have, other cosmetic 
procedures 
 One in fourteen vulvoplasty procedures result in serious complications/adverse 
events 
 The caesarean rate for women with a first birth is 30% higher among those with a 
prior vulvoplasty compared to those without vulvoplasty 
 Among women with a vaginal first birth, there is no difference in perineal 
outcomes between women with and without prior vulvoplasty 
The implications 
 This population-based study provides important information to assist in pre-
surgery counselling 
Abstract 
Objectives: To compare characteristics of women who have vulvoplasty procedures with other 
women; quantify short-term adverse events and complications; and determine any association of 
vulvoplasty on future births. 
Design, setting and participants: A population-based record-linkage study was undertaken using the 
New South Wales (NSW) Admitted Patient Data Collection and NSW Perinatal Data Collection. All 
women who had vulvoplasties in hospital during 2001 - 2013 were identified, and their 
characteristics compared with all women of reproductive age (reference population).  
Main outcome measures: Admissions for vulvoplasty and repeat vulvoplasties; serious 
complications or adverse events following vulvoplasty procedures; birth mode and perineal 
outcomes for primiparous women with and without prior vulvoplasty. 
Results: There were 4,592 vulvoplasty procedures performed on 4,381 women, increasing by 64.5% 
over the study period. Compared to the reference population, women who had vulvoplasty were 
more likely to be Australian born (74.6% vs 67.6%); have other cosmetic surgery (10.1% vs 1.7%); 
and never been married (43.1% vs 33.1%).  The serious adverse event/complication rate was 7.2%. 
Of those with a subsequent first birth, 40.0% had a caesarean section, compared with 30.3% of other 
women (p<0.001); while among vaginal births, perineal outcomes including tears and episiotomies 
were not significantly different (p=0.87; p=0.20). 
Conclusions:  Since 2001, the number of vulvoplasties performed in NSW has increased dramatically, 
with no obvious biological reason for the rise. The procedure was not without serious complications 
necessitating hospital readmission in some instances. This study provides objective outcome 
information for counselling women who are contemplating vulvoplasty. 
Introduction 
Vulvoplasty refers to surgery performed on the external female genitals, generally involving 
reduction of the labia minora and/or correction of asymmetry.1  Over the last two decades there 
have been reports of increasing demand for this procedure, with a concomitant rise in the number 
of procedures performed in high income countries including Australia,1 the United Kingdom2  and the 
United States.3 
 
In Australia, the utilisation of Medical Benefits Schedule (MBS) Item number 35533 for vulvoplasty 
procedure increased from 744 rebates paid in 2003/04 to 1,588 in 2012/13; a doubling over ten 
years.1 This item number was specifically for medically-indicated vulvoplasty procedures performed 
in or out of hospital in private care. However, as no guidance or objective measures were available 
for clinicians to assess medical necessity, concern was raised that increases in Medicare numbers 
might reflect rebates for cosmetic services.1  
 
A review of vulvoplasty services was consequently undertaken by the Department of Health,1  and 
changes were made to the Item number. The previous Medicare item number 35533 (Vulvoplasty) 
was replaced in November 2014 by two Item numbers: 35533 (surgical repair of female genital 
mutilation and major congenital anomalies); and 35534 (surgical repair for localised gigantism 
causing significant functional impairment).4 Rebates were no longer available for out-of-hospital 
services and, available only for Item 35534 where there was documented evidence that a clinical 
need existed. 4 
 
The review incorporated information from both Medicare data and the National Hospital Morbidity 
Data (NHMD). The latter contain vulvoplasty data for procedures performed in both public and 
private hospitals and day stay units, with or without a medical indication, and provided additional 
information regarding hospitalisation. The review reported associated principal diagnoses and age 
profiles for women undergoing vulvoplasty. However, as data were for procedures and not 
individual women, analysis of readmissions or repeat procedures was not possible. Apart from age, 
neither characteristics of women undergoing vulvoplasty, nor rates of any adverse outcomes, were 
reported. No other studies have had the capacity to investigate outcomes at a population level. 
 
The increase in vulvoplasty has attracted discussion and debate within both the medical community  
and the popular media.5, 6  Commentaries have explored possible reasons for this rise 1, 7, 8 as well as 
the ethics of cosmetic surgery marketing.7, 9-11  There is criticism regarding the low level of evidence 
for reporting of short and long-term outcomes, including adverse events.1, 8, 9, 11, 12  Studies have 
relied on surgeon-initiated questionnaires9,13  as well as anecdotal and case reports.11, 13  In addition, 
no studies have been undertaken to date on whether vulvoplasty has effects on subsequent 
childbirth.13, 14  We hypothesised that prior vulvoplasty might impact perineal trauma and/or 
decisions about the mode of delivery. 
 
The aims of this study were to compare characteristics of women undergoing vulvoplasties with 
other women of reproductive age; to quantify serious short-term adverse events; and to determine 
the effect of vulvoplasty on future pregnancy outcomes. 
 
Methods 
The study population consisted of all women of reproductive age (15-54 years) who were admitted 
to hospital in New South Wales (NSW), Australia, for a vulvoplasty procedure during 2001-2013 
inclusive. To explore the relationship between birth outcomes (birth type and perineal status) 
following vulvoplasty, a sub-population included women with a vulvoplasty and a subsequent first 
birth 2001-2012.  
 
Data for this study were sourced from two routinely collected population-based data collections; the 
NSW Admitted Patients Data Collection (otherwise known as ‘hospital data’) 2001-2013, and the 
NSW Perinatal Data Collection (‘birth data’) 1994-2012. The former, an administrative data 
collection, is a census of discharges from all public and private hospitals and day procedure centres. 
As well as demographic data, it contains clinical diagnoses coded according to the International 
Classification of Diseases, Australian Modification (ICD-10-AM), and procedures coded according to 
the Australian Classification of Health Interventions (ACHI) which are based on the Medicare 
Benefits Schedule (MBS).15  The Perinatal Data Collection is a statutory dataset with information 
about all births in NSW public and private hospitals where the gestation ≥ 20 weeks or birthweight ≥ 
400 grams. It contains demographic, medical and obstetric information as well as details regarding 
labour, birth and infant condition. Longitudinal linkage of the hospital records and birth records was 
undertaken by the Centre for Health Record Linkage, enabling admissions, any readmissions or 
serious adverse outcomes, and any birth outcomes to be analysed for each woman. The linkage rate 
between hospital and birth data for mothers has previously been reported as 98.1%.16 Deidentified 
records were provided to researchers.  
 
Vulvoplasty was determined by the Australian Classification of Health Interventions (ACHI) 
procedure code ‘35533-00’ in the medical records. The principal diagnosis at the time of each 
vulvoplasty was determined using ICD-10-AM diagnostic codes. 
 
Factors potentially associated with vulvoplasty and available for analysis included age, marital status, 
smoking, country of birth and socio-economic status (determined using residential postcode to 
assign the Australian Indexes of Disadvantage).17 Cosmetic breast augmentation (for women without 
prior mastectomy or breast cancer diagnosis), liposuction and face/brow lift were also included if 
they had occurred at any time through the study period. All these factors were identified from 
hospital records. 
Information available on the vulvoplasty procedure and health service factors included hospital 
location, public or private care, how many nights the woman was admitted, use of general 
anaesthesia, and if there was readmission within fourteen days.  Serious adverse 
events/complications ascertained from hospital records included haemorrhage, infection and 
urinary adverse events, all of which have previously been reported in smaller non-population 
studies.7 Information ascertained from the birth data included birth mode (non-instrumental vaginal, 
forceps, vacuum, intrapartum caesarean or prelabour caesarean), episiotomy (yes or no), and 
degree of perineal trauma. 
 
The total number of vulvoplasties and the change over time for public and private hospitals were 
calculated. The distribution of characteristics for women with a vulvoplasty was described, and 
compared with NSW reference populations in 2011 for women aged 15-54 years of age, including 
the Australian census data for age and marital status,18 Australian migration data for country of 
birth,19 and the NSW Population Health Survey data for smoking.20 Rates of other cosmetic 
procedures were determined among all women of reproductive age who had no record of 
vulvoplasty and had been admitted to hospital for any other reason during the study period. These 
were compared with the rates of cosmetic surgery among women with vulvoplasty. The 
characteristics of the vulvoplasty procedures and associated health service factors were described. 
 
Women who had a primiparous birth after a vulvoplasty procedure were identified, and their birth 
characteristics were compared with primiparous women without prior vulvoplasty using chi-squared 
analysis. Primiparous women were chosen to minimise any obstetric history effect on birth 
outcomes. 
  
Ethics approval for record linkage was obtained from the NSW Population Health and Health 
Services Research Ethics Committee. 
Results 
During 2001-2013 there were 4,592 vulvoplasty procedures performed on 4,381 women in NSW 
hospitals/day stay centres; 1,198 in public hospitals and 3,394 in private. The number of 
vulvoplasties performed in public hospitals peaked in 2006 (n=122), while those in private hospitals 
continued to rise through 2013 (n=345) (Figure 1). Among all women having a vulvoplasty, 4,193 
(95.7%) had one vulvoplasty, 170 (3.9%) had two vulvoplasties, and 18 (0.4%) had three or more.  
The total number of procedures rose from 256 in 2001 to 421 in 2013, a relative increase of 64.5%.  
 
The two most frequent principal diagnoses associated with vulvoplasties were ‘hypertrophy of vulva’ 
(26.1% in private hospitals, 23.1% in public) and ‘non-inflammatory disorders of vulva or perineum’ 
(19.7% in private hospitals, 21.2% in public). ‘Plastic surgery for unacceptable cosmetic appearance’ 
ranked third among private hospitals (8.1%) and twenty-third among public hospitals (0.7%).   
 
Compared with the general population of women aged 15-54 years of age in NSW, women 
undergoing a vulvoplasty were more likely to be born in Australia (74.6% vs 67.6%) and be 25-34 
years of age (32.7% vs 25.2%); but less likely to be married or in a de facto relationship (42.4% vs 
with 55.4%) and be 45-54 years (16.1% vs 25.5%) (Table 1). They were more likely to live in higher 
socio-economic communities, and six times more likely to have had other cosmetic procedure(s) 
performed during the study period. 
 
Most vulvoplasty procedures were performed in private hospitals in Sydney (59.4%), with the 
remainder performed in public hospitals in Sydney (13.9%), private hospitals outside Sydney (14.5%) 
and public hospitals outside Sydney (12.2%) (Table 2). The majority of women (68.9%) had a day only 
admission.  Of the 679 (14.8%) of women who stayed for two nights or longer, 365 (53.7%) had 
gynaecological surgery other than vulvoplasty recorded as the principal procedure. These 
procedures included repair of uterine prolapse, pelvic floor or enterocele (n=156), and vaginal 
hysterectomy (n=101).  
 
Of the 4,592 vulvoplasties, the procedure was complicated by a serious adverse event (either at the 
time of the vulvoplasty admission or evident at readmission within two weeks) in 332 instances 
(7.2%). The most common were urinary problems/complications (occurring in 3.9% of all 
vulvoplasties) (Table 2). In total, 121 (2.6%) women were readmitted to hospital within two weeks of 
the procedure, with haemorrhage and haematoma complicating a procedure being the most 
common principal diagnosis (n=30), followed by a range of principal diagnoses relating to wound 
complications/infection (n=29). Seven women had a repeat vulvoplasty within two weeks of a 
previous vulvoplasty. 
 
Of all vulvoplasty procedures, 3,157 (68.7%) were among women who had not previously given birth 
in NSW. Women with one prior birth accounted for 694 (15.1%) of all vulvoplasties, women with two 
prior births for 494 (10.8%), and women with three prior births for 247 (5.4%). 
 
There were 257 women with a vulvoplasty who had a subsequent primiparous birth during 2001-
2012. Compared with the 454,027 primiparous births to women without prior vulvoplasty during this 
time, women with a history of vulvoplasty were significantly more likely to have a caesarean section 
(Table 3). This difference was evident among women with either private or public birth care. The 
caesarean rate in private hospitals among women with vulvoplasty was 56.0% compared with 39.7% 
amongst women with no prior vulvoplasty (p=0.004); and in public hospitals, 33.5% compared with 
27.0% (p=0.04). Women with a prior vulvoplasty were also more likely to have a prelabour caesarean 
compared with women with no vulvoplasty (19.8% vs 11.0%), while the rates of intrapartum 
caesarean were similar (20.2% vs 19.3%). Among the vaginal births, there were no significant 
differences in the episiotomy rates nor in perineal trauma for primiparous women with and without 
a previous vulvoplasty (Table 3).  
 
Discussion 
From 2001 to 2013, vulvoplasties performed in NSW hospitals on women aged 15-54 years increased 
by 64.5%.  However, among Australian providers who advertise vulvoplasty surgery services, the 
majority indicate that these procedures are performed on an outpatient basis under local 
anaesthetic.1 For the same period, NSW Medicare rebate data  (which captured clinically-indicated, 
out-of-hospital procedures) showed a 142% increase, suggesting marked increases in both in- and 
out-of-hospital vulvoplasty procedures.21 Following changes to the MBS in 2014, greater restrictions 
were applied to eligibility for Medicare rebates. There has been a subsequent decline in the number 
of vulvoplasties reported by Medicare, with 240 rebates paid in NSW in 2015 compared with 448 in 
2013.4 Data are not (nor have been) available for cosmetic out-of-hospital procedures (i.e. those that 
are not clinically-indicated). Thus the true incidence and trend of vulvoplasty are not able to be 
determined.  
 
It is unlikely that increased vulval pathology is driving the increase in surgery. Concerns regarding 
physical aspects (such as chafing and discomfort), appearance, sexual activity and feeling abnormal 
have been reported as motivators for women to seek surgery.13, 22 However, a wide range of normal 
vulval anatomy exists, and with concern that surgery may exploit vulnerable women, there is a 
growing call from professional bodies for better education and counseling.23, 24 Our study showed a  
six-fold increase in utilisation of other cosmetic procedures among women who have a vulvoplasty 
compared to those without vulvoplasty, implying a lower tolerance for perceived physical 
imperfections.  A similar increase has been reported in a small UK study of 125 women,22 in which 18 
per cent of women with vulvoplasty were also diagnosed with body dysmorphic disorder (compared 
with no diagnoses in the control group). The authors recommended further studies to explore this 
relationship, and others have called for more psychological screening of women who request 
vulvoplasty.23, 25  
 
The quality of evidence in studies of women’s satisfaction after vulvoplasty has been heavily 
criticised in terms of time frames for follow-up and measures used.9 The majority have been 
undertaken by the surgeons who performed the vulvoplasty, with data reported from questionnaires 
to their own patients.9, 13 Impaired sexual functioning from scarring or nerve damage have been 
raised as potential complications following genital surgery.9, 23 Satisfaction and long-term outcomes 
warrant further investigation, especially as the number of women having the procedure (or a repeat 
procedure) outside a hospital is unknown. 
 
In our study, one in fourteen procedures resulted in a serious short-term adverse event or 
complication within two weeks, of which urinary problems were the most common. These are rarely 
mentioned in the literature, with wound dehiscence tending to be reported as the most frequent 
short-term adverse event.1 Our finding of a serious complication rate of 7.2% was slightly higher 
than those reported in other surgeon-led small studies (2.7%  - 6.0%);7  however, other studies also  
included longer term complications  (eg dyspareunia and delayed local pain) which were not able to 
be ascertained by our population data. In using hospital data, only complications or adverse events 
serious enough to warrant a diagnosis or hospital admission could be detected, and complication 
rates may be under-estimated.  Women who were in more pain than they anticipated, were 
unhappy with the aesthetics of the procedure or felt dissatisfied in other ways were not able to be 
definitively captured. Over one in 23 women had a repeat procedure. This may reflect wound 
healing problems after discharge from hospital, or it may reflect longer-term dissatisfaction with 
surgical results.  
 
The association with subsequent birth has not previously been explored.  Among vaginal births, 
perineal outcomes were similar for women with and without vulvoplasty. Based on this, women who 
had a vulvoplasty can be reassured about their prospects for a vaginal birth. However, the rate of 
caesarean section was 30% higher for women with a prior vulvoplasty. The increase was 
predominantly driven by prelabour caesareans, implying a higher rate of planned birth intervention. 
We can only hypothesise regarding the reasons. Prior vulvoplasty surgery may have factored into 
decision-making for birth plans; or surgeons and/or women were concerned that vaginal birth may 
disrupt vulvoplasty results. 
 
This is the first population-based study on vulvoplasty. As such it has avoided sampling bias, and has 
utilised routinely collected data to provide a snapshot of the current situation in NSW hospitals. In 
addition, it has provided information regarding serious complications which can be utilised in pre-
surgery counselling. However, with no routine data available about procedures performed outside 
hospitals, the true incidence was unable to be determined. In addition, vulvoplasties performed 
outside NSW (including overseas) were unable to be captured in this study. 
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Figure 1 – Trend in vulvoplasties performed in NSW hospitals 2001-2013  
0
50
100
150
200
250
300
350
400
2
0
0
1
2
0
0
2
2
0
0
3
2
0
0
4
2
0
0
5
2
0
0
6
2
0
0
7
2
0
0
8
2
0
0
9
2
0
1
0
2
0
1
1
2
0
1
2
2
0
1
3
N
u
m
b
e
r 
o
f 
vu
lv
o
p
la
st
ie
s 
p
e
rf
o
rm
e
d
 in
 
N
SW
 h
o
sp
it
al
s 
Year of vulvoplasty procedure
Private hospital
Public hospital
 
 Table 1 - Characteristics of women (15-54yrs of age) with vulvoplasty compared with reference populations17-20 
 
 No of women=4,381 
Per 100 women with 
vulvoplasty 
Reference population 
per 100 women 
Country of birth  Australia 3269 74.6 67.6  
Elsewhere/Unknown 1112 25.4 32.4  
Cosmetic procedures  Breast &/or liposuction &/or face 444 10.1 1.7 
Details of individual cosmetic 
procedures 
Breast augmentation 236 5.4 0.9  
Liposuction 230 5.3 0.8  
Face/brow lift 44 1.0 0.2  
  
Women at the time of the vulvoplasty 
procedure 2001-2013 
N=4,592 procedures 
Per 100 vulvoplasty 
procedures 
2001-2013 
Reference population 
per 100 women 
 
Age (yrs)  15-24 1152  25.1 23.1 
25-34 1500  32.7 25.2 
35-44 1199  26.1 26.3 
45-54 741  16.1 25.5 
Marital status
 
 Never married 1978  43.1 33.1 
Married/de facto 1947  42.4 55.4  
Widowed/divorced/separated 462  10.1 11.6 
Unknown 205  4.5 ---- 
Smoking  Yes 725 15.8 14.2 
Socio Economic Status (from 
postcode) at time of procedure  
1 Most disadvantaged 413 9.0 20.0 
2 553 12.1 20.0 
3 965 21.0 20.0 
4 996 21.7 20.0 
5 Least disadvantaged 1507 32.8 20.0 
Unknown (residence outside NSW) 158 3.4 ---- 
 Table 2 - Characteristics of vulvoplasty procedures 
  
Vulvoplasty procedure  
2001-2013 
n=4,592 
Per 100 vulvoplasty 
procedures 
2001-2013 
Hospital 
 
 
Public - Sydney 638 13.9 
Private - Sydney 2729 59.4 
Public - outside Sydney 560 12.2 
Private - outside Sydney 665 14.5 
Hospital stay 
Day only 3165 68.9 
1 night 748 16.3 
2 nights 299 6.5 
> 2 nights 380 8.3 
Anaesthesia General 4363  95.0 
Any serious adverse event * Yes 332  7.2 
Details of serious adverse event*      Haemorrhage 82  1.8 
      Infection 14 0.3 
      Urinary  181 3.9 
      Other** 73 1.6 
Readmission within 2 weeks of procedure Yes 121  2.6 
*Serious adverse event occurring during procedure admission or readmission within 2 weeks (some women had more than 
one serious adverse event) 
**Other includes disruption of operation wound and other complications 
 
Table 3 - Comparison of birth outcomes 2001-2012 by prior vulvoplasty among primiparous 
women 
  Among women 
with previous 
vulvoplasty 
n=257 (col %) 
Among women without 
previous vulvoplasty  
n=454,027 
p  
(chi-squared) 
Hospital Public 182 (70.8) 333618 (73.50) p=0.33 
Private 75 (29.2) 120409 (26.52) 
Birth mode Non instrumental vaginal  118 (45.9) 225042 (49.57) p<0.001 
Forceps 10 (3.9) 33008 (7.27) 
Vacuum 26 (10.1) 57971 (12.77) 
Intrapartum CS 52 (20.2) 87650 (19.31) 
Prelabour CS 51 (19.8) 50134 (11.04) 
Missing data ---- 222 (<0.05)  
Episiotomy among 
vaginal births 
Yes 37 (24.0) 90550 (28.65) p=0.20 
No  117 (76.0) 225471 (71.35) 
Perineal spontaneous 
tearing (among vaginal 
births)* 
Intact/1
st
 degree tear 66 (42.9) 118028 (37.35) p=0.87 
2
nd
 degree tear 46 (29.9) 90690 (28.70) 
3
rd
/ 4
th
 degree tear 5 (3.3) 12681 (4.01) 
Other 30 (19.5) 58042 (18.37) 
*do not total 100% as perineal categories were not mutually exclusive with episiotomy <2007. 
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